The first half of 2005 was marked by several major acquisitions by the companies in the BioCommerce Week Index. Qiagen and Invitrogen were the most aggressive in adding pieces to their businesses. Perhaps the most anticipated acquisition, however, was announced last week with Takara Bio inking an agreement to buy Becton Dickinson's Clontech unit (see article in this week's issue).

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.